Reports
Sale
Global Digital Therapeutics Market Size, Share, Forecast: By Application: Preventive, Treatment; By Component: Software, Device; By End-user: Patients, Providers, Payers, Employers, Others; By Sales Channel: B2B, B2C; Regional Analysis; Market Dynamics: SWOT Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032
Global Digital Therapeutics Market Outlook
The global digital therapeutics market size was valued at USD 4.5 billion in 2023, driven by the growing prevalence of telehealth services across the globe. The market is expected to grow at a CAGR of 31.6% during the forecast period of 2024-2032, with the values likely to rise from USD 5.92 billion in 2024 to USD 53.2 billion by 2032.
Global Digital Therapeutics Market Overview
Digital therapeutics are therapeutic interventions that help in patient treatment, management, and disease prevention with the help of evidence based and clinically evaluated software. It delivers therapies using smartphones, tablets and similar technologies and offers clinically safe and effective therapies to patients. The market is impacted by the increasing prevalence of chronic diseases and the rising convergence of digital technologies, artificial intelligence, and machine learning capabilities along with the advent of sensor capabilities.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increased Application in Clinical Trials to Aid the Market Growth
In December 2023, ObvioHealth announced the launch of their new API (application programming interface), tailored particularly for digital therapeutic clinical trials. The new electronic clinical outcome assessment (eCOA) solution integrates enhanced study design technology with scientific and clinical services. It enables rapid publishing of the assessment on the mobile apps to offer more robust results for trial sponsors. It also evaluates patient engagement tactics and offers personalized assistance to patients, ensuring their safety as well.
Rising Collaborations Between Pharmaceutical Giants and Prescription Digital Therapeutics Makers
With the vision to integrate technology related components in their product range and enter the digital health space, several pharmaceutical companies have started partnering with PDTs. In September 2023, Bayer AG entered a partnership with Mahana Therapeutics to commercialize irritable bowel syndrome (IBS) related digital therapies. Mahana IBS, the company’s lead product uses cognitive behavioral therapy (CBT) to impact gut-brain communication. The agenda of such collaborations is primarily focused on connecting consumers with digital health tools. Hence, it is expected to impact the digital therapeutics market growth substantially.
Innovative Product Launches for Enhanced Services to Significantly Benefit the Market
To improve the quality of patient care in the upcoming ages, healthcare companies have realized that digital therapeutics is poised to play an active role in healthcare management. The shift has been significant, especially post COVID-19. Consequently, there have been comprehensive upgrades and new product launches to meet the rising digital therapeutics market demand. In November 2023, the Digital Therapeutics Alliance (DTA) launched a Policymaker & Payor DTx Evaluation Toolkit, which includes components like foundation setting materials, DTx assessment guides and implementation resources. It featured market access pathways, prescription vs non-prescription statuses, along with clinical and economic impact of products along with its security, privacy, usability, and evidence requirements.
Software Segment is Expected to Lead the Digital Therapeutics Market Share
Based on components, the market is broadly divided into software and devices. Out of the two, the software segment is projected to dominate the market, which can be attributed to rising prevalence of applications that improve the user interface and convenience for both patients and healthcare providers. There has been continuous development in the existing models to bring relevant changes. One such example is Freespira’s Bluetooth wireless technology enabled devices which come with sensor samples, measuring exhaled carbon dioxide and respiration rate, and directly transmitting the data to Freespira’s application.
Growing Emphasis on Preventive Healthcare in the Geriatric Population
The rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics are all driving the digital therapeutics market growth. Chronic diseases' high incidence rate is a serious problem for healthcare systems all over the world. Patients with chronic diseases provide a considerable barrier in terms of therapy, since psychosomatic or biopsychic variables frequently affect these patients. Many chronic diseases and conditions progress over time, and their prevalence rises as people get older. As a result, chronic diseases are expected to rise even more throughout the forecast period as the global geriatric population grows. This is expected to provide considerable growth opportunities for the digital therapeutics industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Digital Therapeutics Market Segmentation
Market Breakup by Application
- Preventive
- Prediabetes
- Obesity
- Others
- Treatment
- Diabetes
- Respiratory Care
- Mental Health
- Cardiovascular
- Others
Market Breakup by Component
- Software
- Device
Market Breakup by End-user
- Patients
- Providers
- Payers
- Employers
- Others
Market Breakup by Sales Channel
- B2B
- B2C
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Digital Therapeutics Market Regional Analysis
The United States, with a robust healthcare infrastructure that can integrate the digital advancements, is expected to dominate the digital therapeutics market size in the forecast period. The existence of impactful academic as well as research institutions drives the market growth in the region. The increasing adoption of telehealth services is another major aspect.
In March 2023, NeuroRPM received the FDA clearance for using artificial intelligence enabled remote monitoring app for Parkinson’s disease. It monitors the disease indications such as bradykinesia, tremor, and dyskinesia continuously using proprietary algorithms. This indicates the ongoing trend of healthcare practitioners and companies adopting digital services to improve the treatment alternatives for patients. Similar have been employed for migraine, PTSD, psychiatric conditions, and chronic lung diseases like CAD as well.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Digital Therapeutics Market: Competitor Landscape
In October 2023, Sidekick Health acquired aidhere, a Germany based pioneer of prescription digital therapeutics. This acquisition also loops in zanadio, which is one of the most successful PDTs with over 50,000 prescriptions and is recognised within Germany’s self-regulated DiGA. It strengthens Sidekick Health’s portfolio as a trusted partner for pharmaceutical giants and global health insurers.
The market has been flourished with relevant developments, wherein several companies have been undergoing significant transformations to expand their product portfolio. The key features of the digital therapeutics market report include grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Omada Health, Inc.
- Welldoc, Inc.
- 2Morrow, Inc
- Livongo Health, Inc. (Teladoc Health, Inc.)
- Propeller Health (ResMed)
- Fitbit LLC
- Mango Health
- Canary Health
- Noom, Inc.
- Pear Therapeutics, Inc.
- Akill Interactive Labs, Inc.
- JOGO Health
- GAIA AG
- CureApp, Inc.
- Brain+ A/S
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Applications |
|
| Breakup by Component |
|
| Breakup by End User |
|
| Breakup by Sales Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digital Therapeutics Market Overview
3.1 Global Digital Therapeutics Market Historical Value (2017-2023)
3.2 Global Digital Therapeutics Market Forecast Value (2024-2032)
4 Global Digital Therapeutics Market Landscape
4.1 Global Digital Therapeutics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digital Therapeutics Product Landscape
4.2.1 Analysis by Application
4.2.1 Analysis by Component
4.2.2 Analysis by End-user
4.2.3 Analysis by Sales Channel
5 Global Digital Therapeutics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digital Therapeutics Market Segmentation
6.1 Global Digital Therapeutics Market by Application
6.1.1 Market Overview
6.1.1.1 Preventive
6.1.1.1.1 Prediabetes
6.1.1.1.2 Obesity
6.1.1.1.3 Others
6.1.1.2 Treatment
6.1.1.2.1.1 Diabetes
6.1.1.2.1.2 Respiratory Care
6.1.1.2.1.3 Mental Health
6.1.1.2.1.4 Cardiovascular
6.1.1.2.1.5 Others
6.2 Global Digital Therapeutics Market by Component
6.2.1 Market Overview
6.2.2 Software
6.2.3 Device
6.3 Global Digital Therapeutics Market by End-user
6.3.1 Market Overview
6.3.2 Patients
6.3.3 Providers
6.3.4 Payers
6.3.5 Employers
6.3.6 Others
6.4 Global Digital Therapeutics Market by Sales Channel
6.4.1 Market Overview
6.4.2 B2B
6.4.3 B2C
6.5 Global Digital Therapeutics Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Digital Therapeutics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Digital Therapeutics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Digital Therapeutics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Digital Therapeutics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Digital Therapeutics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by Year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Omada Health, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Welldoc, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 2Morrow, Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Livongo Health, Inc. (Teladoc Health, Inc.)
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Propeller Health (ResMed)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Fitbit LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Mango Health
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Canary Health
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Noom, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Pear Therapeutics, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Akill Interactive Labs, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 JOGO Health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 GAIA AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 CureApp, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Brain+ A/S
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Digital Therapeutics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 4.5 billion in 2023, driven by the prevalence of telehealth services across the globe.
The market is anticipated to grow at a CAGR of 31.6% during the forecast period of 2024-2032, likely to reach a market value of USD 53.2 billion by 2032.
The market demand is driven by the increasing prevalence of chronic diseases, growing geriatric population, and rising convergence of digital health and related services in the healthcare ecosystem.
The major market trend revolves around increasing mergers and collaborations between influential healthcare companies, aimed at expanding their product lines and offer digital health services to the patients. In September 2023, Bayer AG entered a collaboration with Mahana Therapeutics to commercialize irritable bowel syndrome (IBS) related digital therapies.
Software and devices are common components available in the market.
Common application areas include preventive care and treatment. Preventive is further segmented into prediabetes, obesity, and others. Treatment divides into diabetes, respiratory care, mental health, cardiovascular and others.
Based on sales channels, the market is divided into B2B and B2C.
Major end users include patients, providers, payers, employers, and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Omada Health, Inc, Welldoc, Inc., 2Morrow, Inc., Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, Mango Health, Canary Health, Noom, Inc., Pear Therapeutics, Inc., Akill Interactive Labs, Inc., JOGO Health, GAIA AG, CureApp, Inc. and Brain+ A/S.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER